Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

Inclusion Criteria: * Must have TFBUT of ≤ 5 seconds in at least one eye at Screening visit. * Must have best corrected visual acuity (BCVA) of ≥ 20/80 (or ≥ 55 letters score or ≥ 0.6 early treatment diabetic retinopathy study (ETDRS) log of the minimum angle of resolution (LogMAR) value) in both eyes at the Screening visit. * Must be willing to discontinue use of all artificial tear supplements and use only the study product as directed for the entire study duration. Exclusion Criteria: * History of hypersensitivity to the study drug or any of its excipients or to drugs of similar chemical classes. * Use of any topical ocular medication preserved with benzalkonium chloride or other products known to be toxic to the tear film lipid layer within 1 month prior to the Screening visit. Other protocol-specified inclusion and exclusion criteria may apply.